United States · 
Who invested in ProLynx?
ProLynx's investors include National Science Foundation, OrbiMed, National Institutes of Health and 5AM Ventures.
United States · Series A startup
Who invested in ProLynx
Funding summaryUpdated 26 Oct 2026
$70Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $70MDec 2025
- Investors
- 4
The rounds
- Dec 2025Series A$70M
Source recorded
Founders and team
From the SEC filings it signed: 2 on the team.
- Daniel SantiExecutive Officer, Directori
- Scott J. KarchmerExecutive Officeri
On the board, as filediAnurag BagariaMarc EdwardsMichael RabsonWilliam J. Rutter
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about ProLynx
How much has ProLynx raised?
ProLynx has raised $70M across 1 round since 2025.
When did ProLynx last raise?
ProLynx's most recent round was a Series A of $70M in Dec 2025.
What was ProLynx's biggest round?
Its most recent round, $70M in Dec 2025, is also its largest on record.
Who backed ProLynx first?
ProLynx's first round on record, in Dec 2025, was backed by National Science Foundation, OrbiMed and National Institutes of Health and 1 others.
What stage is ProLynx at?
ProLynx's latest named round is a Series A, in Dec 2025.
Where is ProLynx based?
ProLynx is based in the United States.
Companies like ProLynx
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.